Looking at albumin as a prognostic factor in ovarian cancer, Ataseven et al. has shown that pretherapeutic hypoalbuminemia was associated with a higher rate of postoperative complications and impaired overall survival [44]. This evidence concerns the gene ALB and ovarian cancer.